ELMOD2
ELMO domain-containing protein 2
Also known as: ELMD2_HUMAN, MGC10084
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZ81
- Gene
- ELMOD2
- Ensembl
- ENSG00000179387
- Chromosome
- 4
- Canonical length
- 293 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Actin filaments,Cytosol
OverviewNCBI Gene
This gene encodes one of six engulfment and motility (ELMO) domain-containing proteins. This gene is thought to play a role in antiviral responses. Mutations in this gene may be involved in the cause of familial idiopathic pulmonary fibrosis. [provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q8IZ81|ELMOD2
1 MFISLWEFFY GHFFRFWMKW LLRQMTGKCE LQRIFDTYVG AQRTHRIENS LTYSKNKVLQ
61 KATHVVQSEV DKYVDDIMKE KNINPEKDAS FKICMKMCLL QITGYKQLYL DVESVRKRPY
121 DSDNLQHEEL LMKLWNLLMP TKKLNARISK QWAEIGFQGD DPKTDFRGMG ILGLINLVYF
181 SENYTSEAHQ ILSRSNHPKL GYSYAIVGIN LTEMAYSLLK SEALKFHLYN LVPGIPTMEH
241 FHQFYCYLVY EFDKFWFEEE PESIMYFNLY REKFHEKIKG LLLDCNVALT LKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELMOD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- retina: 17 nTPM
- thyroid gland: 16 nTPM
- liver: 15 nTPM
- parathyroid gland: 15 nTPM
- small intestine: 14 nTPM
- kidney: 14 nTPM
Single-cell type
- adrenal medulla cells: 64 nCPM
- prostatic glandular cells: 58 nCPM
- ependymal cells: 57 nCPM
- cardiomyocytes: 55 nCPM
- gonadotrophs: 54 nCPM
- corticotrophs: 52 nCPM
Immune cell
- neutrophil: 15 nTPM
- plasmacytoid DC: 9.8 nTPM
- eosinophil: 8.1 nTPM
- NK-cell: 7.6 nTPM
- MAIT T-cell: 7.4 nTPM
- T-reg: 7.3 nTPM
Brain region
- choroid plexus: 27 nTPM
- white matter: 23 nTPM
- cerebellum: 21 nTPM
- spinal cord: 19 nTPM
- medulla oblongata: 19 nTPM
- hypothalamus: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ELMOD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELMOD2 as an antibody target. Whether an autoantibody or antibody against ELMOD2 could matter depends on whether native ELMOD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELMOD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELMOD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...